Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 6 studies | 54% ± 17% | |
hepatocyte | 5 studies | 50% ± 21% | |
epithelial cell of proximal tubule | 4 studies | 19% ± 2% | |
astrocyte | 4 studies | 28% ± 7% | |
fibroblast | 4 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of RGN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 7948.53 | 226 / 226 | 97% | 125.40 | 393 / 406 |
kidney | 100% | 2547.45 | 89 / 89 | 93% | 19.86 | 838 / 901 |
thymus | 99% | 1538.42 | 649 / 653 | 85% | 24.97 | 514 / 605 |
adrenal gland | 100% | 14751.05 | 258 / 258 | 84% | 54.50 | 193 / 230 |
brain | 100% | 1512.86 | 2638 / 2642 | 79% | 15.87 | 560 / 705 |
prostate | 99% | 1179.39 | 242 / 245 | 66% | 5.90 | 331 / 502 |
pancreas | 100% | 1542.76 | 328 / 328 | 58% | 6.31 | 104 / 178 |
ovary | 100% | 1741.03 | 180 / 180 | 45% | 4.32 | 192 / 430 |
lung | 99% | 1590.57 | 571 / 578 | 38% | 3.94 | 444 / 1155 |
stomach | 99% | 784.95 | 355 / 359 | 21% | 3.30 | 61 / 286 |
uterus | 96% | 664.28 | 164 / 170 | 14% | 1.51 | 64 / 459 |
blood vessel | 99% | 1322.76 | 1326 / 1335 | 0% | 0 | 0 / 0 |
bladder | 81% | 653.76 | 17 / 21 | 12% | 1.14 | 58 / 504 |
heart | 91% | 776.12 | 783 / 861 | 0% | 0 | 0 / 0 |
esophagus | 73% | 546.24 | 1053 / 1445 | 15% | 1.71 | 28 / 183 |
breast | 66% | 265.44 | 302 / 459 | 17% | 1.73 | 187 / 1118 |
intestine | 64% | 408.42 | 620 / 966 | 12% | 1.51 | 63 / 527 |
adipose | 69% | 295.61 | 825 / 1204 | 0% | 0 | 0 / 0 |
muscle | 63% | 256.34 | 508 / 803 | 0% | 0 | 0 / 0 |
spleen | 62% | 254.91 | 150 / 241 | 0% | 0 | 0 / 0 |
skin | 24% | 74.62 | 435 / 1809 | 1% | 0.33 | 3 / 472 |
eye | 0% | 0 | 0 / 0 | 3% | 0.17 | 2 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.09 | 1 / 45 |
peripheral blood | 1% | 11.80 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007283 | Biological process | spermatogenesis |
GO_0019853 | Biological process | L-ascorbic acid biosynthetic process |
GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
GO_1901318 | Biological process | negative regulation of flagellated sperm motility |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0001822 | Biological process | kidney development |
GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_1903011 | Biological process | negative regulation of bone development |
GO_1903052 | Biological process | positive regulation of proteolysis involved in protein catabolic process |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0097421 | Biological process | liver regeneration |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0010907 | Biological process | positive regulation of glucose metabolic process |
GO_1902679 | Biological process | negative regulation of RNA biosynthetic process |
GO_1903625 | Biological process | negative regulation of DNA catabolic process |
GO_2000279 | Biological process | negative regulation of DNA biosynthetic process |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004341 | Molecular function | gluconolactonase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030234 | Molecular function | enzyme regulator activity |
Gene name | RGN |
Protein name | Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30) |
Synonyms | SMP30 |
Description | FUNCTION: Gluconolactonase with low activity towards other sugar lactones, including gulonolactone and galactonolactone. Can also hydrolyze diisopropyl phosphorofluoridate and phenylacetate (in vitro). Calcium-binding protein. Modulates Ca(2+) signaling, and Ca(2+)-dependent cellular processes and enzyme activities (By similarity). . |
Accessions | ENST00000457380.5 [Q15493-2] ENST00000397180.6 [Q15493-1] ENST00000336169.3 [Q15493-1] ENST00000352078.8 [Q15493-1] Q15493 |